Distribution of patients with elevated ferritin by disorder
| Disorder . | N (% [90% confidence interval]) . | Ferritin (×103 µg/L), median [range] . |
|---|---|---|
| Renal failure | 73 (65 [57-72]) | 84 [50-440] |
| Hepatocellular injury | 61 (54 [46-62]) | 83 [50-440] |
| Infection | 52 (46 [38-54]) | 87 [52-440] |
| Hematologic malignancy | 36 (32 [25-40]) | 98 [52-233] |
| Rheumatologic/inflammatory | 20 (18 [12-25]) | 68 [50-341] |
| HLH | 19 (17 [11-24]) | 99 [52-233] |
| Iron overload | 13 (12 [7-18]) | 101 [76-440] |
| Hemolytic anemia | 5 (4 [2-9]) | 149 [80-203] |
| Solid tumor | 5 (4 [2-9]) | 72 [52-95] |
| MAS | 3 (3 [1-7]) | 61 [56-341] |
| None | 2 (2 [0-4]) | 123 [118-127] |
| Disorder . | N (% [90% confidence interval]) . | Ferritin (×103 µg/L), median [range] . |
|---|---|---|
| Renal failure | 73 (65 [57-72]) | 84 [50-440] |
| Hepatocellular injury | 61 (54 [46-62]) | 83 [50-440] |
| Infection | 52 (46 [38-54]) | 87 [52-440] |
| Hematologic malignancy | 36 (32 [25-40]) | 98 [52-233] |
| Rheumatologic/inflammatory | 20 (18 [12-25]) | 68 [50-341] |
| HLH | 19 (17 [11-24]) | 99 [52-233] |
| Iron overload | 13 (12 [7-18]) | 101 [76-440] |
| Hemolytic anemia | 5 (4 [2-9]) | 149 [80-203] |
| Solid tumor | 5 (4 [2-9]) | 72 [52-95] |
| MAS | 3 (3 [1-7]) | 61 [56-341] |
| None | 2 (2 [0-4]) | 123 [118-127] |